• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The distribution of quinidine in human blood.奎尼丁在人体血液中的分布。
Br J Clin Pharmacol. 1975 Dec;2(6):521-5. doi: 10.1111/j.1365-2125.1975.tb00570.x.
2
The uptake of fentanyl by erythrocytes.红细胞对芬太尼的摄取。
J Pharm Pharmacol. 1982 Mar;34(3):181-5. doi: 10.1111/j.2042-7158.1982.tb04217.x.
3
Influence of plasma pH on quinidine uptake by erythrocytes: estimation of free drug fraction in plasma from blood/and erythrocyte/plasma concentration ratios.
Pharm Acta Helv. 1987;62(2):61-4.
4
Factors influencing the apparent protein binding of quinidine.
J Pharm Sci. 1982 Mar;71(3):325-8. doi: 10.1002/jps.2600710316.
5
Apparent stereoselectivity in propafenone uptake by human and rat erythrocytes.普罗帕酮在人和大鼠红细胞摄取过程中表现出的立体选择性。
Biopharm Drug Dispos. 1991 May;12(4):299-310. doi: 10.1002/bdd.2510120407.
6
Distribution of sodium valproate in normal whole blood and in blood from patients with renal or hepatic disease.
Eur J Clin Pharmacol. 1985;28(4):447-52. doi: 10.1007/BF00544365.
7
Quinidine and dihydroquinidine interactions in human plasma.
J Pharm Sci. 1979 Apr;68(4):448-50. doi: 10.1002/jps.2600680414.
8
Pharmacokinetic and clinical implications of quinidine protein binding.
J Pharm Sci. 1979 Apr;68(4):466-70. doi: 10.1002/jps.2600680419.
9
Pharmacokinetics of quinidine related to plasma protein binding in man.
Eur J Clin Pharmacol. 1979 Apr 17;15(3):187-92. doi: 10.1007/BF00563104.
10
Binding of quinidine to a red blood cell hemolysate preparation.奎尼丁与红细胞溶血产物制剂的结合。
J Pharm Sci. 1974 Aug;63(8):1267-71. doi: 10.1002/jps.2600630822.

引用本文的文献

1
Development of a physiologically-based pharmacokinetic model of the rat central nervous system.大鼠中枢神经系统生理基于模型的药代动力学模型的开发。
Pharmaceutics. 2014 Mar 18;6(1):97-136. doi: 10.3390/pharmaceutics6010097.
2
Quinine and quinidine inhibit and reveal heterogeneity of K-Cl cotransport in low K sheep erythrocytes.奎宁和奎尼丁抑制并揭示了低钾绵羊红细胞中钾氯共转运的异质性。
J Membr Biol. 1994 Nov;142(2):195-207. doi: 10.1007/BF00234941.
3
Clinical pharmacokinetics of quinidine.奎尼丁的临床药代动力学。
Clin Pharmacokinet. 1980 Mar-Apr;5(2):150-68. doi: 10.2165/00003088-198005020-00003.
4
Prediction of the volumes of distribution of basic drugs in humans based on data from animals.基于动物数据预测碱性药物在人体中的分布容积。
J Pharmacokinet Biopharm. 1984 Dec;12(6):587-96. doi: 10.1007/BF01059554.
5
Disease-induced changes in the plasma binding of basic drugs.疾病引起的碱性药物血浆结合变化。
Clin Pharmacokinet. 1980 May-Jun;5(3):246-62. doi: 10.2165/00003088-198005030-00004.
6
Analysis of nonlinear tissue distribution of quinidine in rats by physiologically based pharmacokinetics.基于生理药代动力学对大鼠体内奎尼丁非线性组织分布的分析。
J Pharmacokinet Biopharm. 1985 Aug;13(4):425-40. doi: 10.1007/BF01061478.
7
Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.根据大鼠药代动力学参数预测九种弱酸性和六种弱碱性药物在人体内的处置情况。
J Pharmacokinet Biopharm. 1985 Oct;13(5):477-92. doi: 10.1007/BF01059331.
8
Distribution of sodium valproate in normal whole blood and in blood from patients with renal or hepatic disease.
Eur J Clin Pharmacol. 1985;28(4):447-52. doi: 10.1007/BF00544365.
9
Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method.胺碘酮在患者群体中的血浆蛋白结合:通过红细胞分配和一种新型玻璃结合法进行测量
Br J Clin Pharmacol. 1988 Dec;26(6):721-31. doi: 10.1111/j.1365-2125.1988.tb05311.x.
10
Clinical pharmacokinetic considerations in the elderly. An update.老年人的临床药代动力学考量。最新进展。
Clin Pharmacokinet. 1989 Oct;17(4):236-63. doi: 10.2165/00003088-198917040-00003.

本文引用的文献

1
QUANTITATIVE DETERMINATION OF QUINIDINE IN PLASMA.血浆中奎尼丁的定量测定
Scand J Clin Lab Invest. 1963;15:553-6. doi: 10.1080/00365516309079786.
2
The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.人红细胞无血红蛋白空泡的制备及其化学特性
Arch Biochem Biophys. 1963 Jan;100:119-30. doi: 10.1016/0003-9861(63)90042-0.
3
The relation between the binding of sulfonamides to albumin and their antibacterial efficacy.磺胺类药物与白蛋白的结合与其抗菌效力之间的关系。
J Pharmacol Exp Ther. 1960 Jul;129:282-90.
4
Passage of organic bases into human red cells.有机碱进入人体红细胞的过程。
J Pharmacol Exp Ther. 1961 Sep;133:325-31.
5
Comparison of two methods for quinidine determination and chromatographic analysis of the difference.
Clin Chim Acta. 1969 Feb;23(2):289-94. doi: 10.1016/0009-8981(69)90043-6.
6
Drug therapy. Serum drug concentrations as therapeutic guides.药物治疗。作为治疗指导的血清药物浓度。
N Engl J Med. 1972 Aug 3;287(5):227-31. doi: 10.1056/NEJM197208032870505.
7
Erythrocyte uptake and plasma binding of diphenylhydantoin.
Clin Pharmacol Ther. 1974 Aug;16(2):355-62. doi: 10.1002/cpt1974162355.
8
Quinidine elimination in patients with congestive heart failure or poor renal function.
N Engl J Med. 1974 Mar 28;290(13):706-9. doi: 10.1056/NEJM197403282901303.
9
Disposition of propranolol. VI. Independent variation in steady-state circulating drug concentrations and half-life as a result of plasma drug binding in man.普萘洛尔的处置。VI. 人体中血浆药物结合导致稳态循环药物浓度和半衰期的独立变化。
Clin Pharmacol Ther. 1973 Jul-Aug;14(4):494-500. doi: 10.1002/cpt1973144part1494.
10
Effect of protein binding on the distribution of 5,5-diphenylhydantoin between plasma and red cells.
Ann N Y Acad Sci. 1973 Nov 26;226:82-7. doi: 10.1111/j.1749-6632.1973.tb20470.x.

奎尼丁在人体血液中的分布。

The distribution of quinidine in human blood.

作者信息

Hughes I E, Ilett K F, Jellett L B

出版信息

Br J Clin Pharmacol. 1975 Dec;2(6):521-5. doi: 10.1111/j.1365-2125.1975.tb00570.x.

DOI:10.1111/j.1365-2125.1975.tb00570.x
PMID:1234016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1402636/
Abstract

The uptake of quinidine by washed human red blood cells from isotonic buffer solution (pH 7.4) occurred rapidly and was proportional to the concentration of drug in buffer. A constant red cell/buffer partition ratio of 4.16+/-0.15 s.e. mean was found. 2. Uptake from buffer solution was not affected by temperature or ouabain or by gassing with nitrogen or carbon monoxide and there was no evidence of saturability. Drug in red blood cells was associated largely with the cell contents (94.4+/-1.5% s.e. mean) following partition. 3 Plasma reduced the uptake of quinidine so that a red cell/plasma partition ratio of 0.82+/-0.09 s.e. mean was found. 4 Alteration of plasma binding by dilution of plasma with buffer showed that uptake was proportional to free drug concentration. 5 The possibility of red cell uptake of drug should be included in any considerations concerning pharmacokinetic aspects of drug action in the body.

摘要

从等渗缓冲溶液(pH 7.4)中洗过的人红细胞对奎尼丁的摄取迅速,且与缓冲液中药物浓度成正比。发现红细胞/缓冲液的恒定分配比为4.16±0.15(标准误均值)。2. 从缓冲溶液中的摄取不受温度、哇巴因影响,也不受用氮气或一氧化碳通气的影响,且没有饱和性的证据。在分配后,红细胞中的药物主要与细胞内容物相关(94.4±1.5%,标准误均值)。3. 血浆降低了奎尼丁的摄取,因此发现红细胞/血浆分配比为0.82±0.09(标准误均值)。4. 用缓冲液稀释血浆改变血浆结合表明,摄取与游离药物浓度成正比。5. 在任何关于药物在体内作用的药代动力学方面的考虑中,都应包括红细胞摄取药物的可能性。